In 1998 was created Sofimac Innovation, which is appeared as VC.
The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Exeliom, Igyxos, eLichens. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Electronics, Information Technology.
The fund is constantly included in 2-6 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 9 percentage points less often commits exit comparing to other companies. The top activity for fund was in 2018.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Sofimac Innovation, startups are often financed by Sofimac Partners, Cru00e9dit Agricole, Bpifrance. The meaningful sponsors for the fund in investment in the same round are Bpifrance, Cemag Invest, BNP Paribas Du00e9veloppement. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs.
Related Funds
| Fund Name | Location |
| BMNT | California, Palo Alto, United States |
| Cloud Power Capital | Austin, Texas, United States |
| Da Vinci Capital | Castel, Guernsey, Guernsey |
| Echelon Capital | - |
| Hegemon Group International | - |
| Landmark Partners | Connecticut, Simsbury, United States |
| Latona Associates | - |
| Le Studio VC | France, Ile-de-France, Paris |
| LEVERAGE Japan | Japan, Tokyo |
| Mark Ventures | Argentina, Buenos Aires, Distrito Federal |
| Rocketmakers | Bath, Bath and North East Somerset, United Kingdom |
| Rt Capital Management | Canada, Halifax, Nova Scotia |
| Seoul Semiconductor | Seoul, Seoul-t'ukpyolsi, South Korea |
| Sinopharm Capital | China, Shanghai |
| Soaring Capital | Beijing, Beijing, China |
| Teakwood Capital | Dallas, Texas, United States |
| Zen Water Capital | - |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
GLIMPS | $7M | 13 Apr 2021 | France, Brittany, France | ||
AcuSurgical | $6M | 18 Feb 2021 | Montpellier, Languedoc-Roussillon, France | ||
Stirweld | $2M | 17 Feb 2021 | France, Brittany, France | ||
Antaios | $11M | 16 Dec 2020 | France, Auvergne-Rhône-Alpes | ||
Vulkam | $4M | 04 Feb 2020 | France, Auvergne-Rhône-Alpes | ||
Beekast | $5M | 01 Jan 2020 | France, Ile-de-France | ||
Diabeloop | $36M | 02 Dec 2019 | Grenoble, Auvergne-Rhône-Alpes, France | ||
Igyxos | $8M | 21 Mar 2019 | France, Centre-Loire Valley | ||
ISORG | $28M | 26 Sep 2018 | France, Auvergne-Rhône-Alpes |
– Nestwave is a Paris, France-based provider of low-power geolocation IP and cloud services for Internet of Things (IoT) applications.
– The company secured a €2.4m round of financing.
– Backers included the European Innovation Council, the European Commission’s newly established venture capital fund, and current investors Sofimac Innovation (Paris, France) and The Faktory Fund (Liege, Belgium).
– The new investment will be used to further accelerate the rollout of its hybrid-signal global navigation satellite system (GNSS) and cellular positioning technologies.
– AcuSurgical, a Montpellier, France-based company focused on robotic microsurgery, raised €5.75m in Series A financing.
– The round was led by Mérieux Equity Partners (via OMX Europe Venture Fund) and Supernova Invest (via Supernova 2 Fund), with Sofimac Innovation (via Pertinence Invest 2 Fund) and IRDI Capital Investissement (via Irdinov 2 and Inn’Vest PME Occitanie Est Funds) participating.
– The company intends to use the funds to conduct clinical trials and reach regulatory approval with vitreo-retinal surgery as the first indication.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
GLIMPS | $7M | 13 Apr 2021 | France, Brittany, France | ||
AcuSurgical | $6M | 18 Feb 2021 | Montpellier, Languedoc-Roussillon, France | ||
Stirweld | $2M | 17 Feb 2021 | France, Brittany, France | ||
Antaios | $11M | 16 Dec 2020 | France, Auvergne-Rhône-Alpes | ||
Vulkam | $4M | 04 Feb 2020 | France, Auvergne-Rhône-Alpes | ||
Beekast | $5M | 01 Jan 2020 | France, Ile-de-France | ||
Diabeloop | $36M | 02 Dec 2019 | Grenoble, Auvergne-Rhône-Alpes, France | ||
Igyxos | $8M | 21 Mar 2019 | France, Centre-Loire Valley | ||
ISORG | $28M | 26 Sep 2018 | France, Auvergne-Rhône-Alpes |
